Joanna Van

3.0k citations
6 papers · 938 indexed · 1 hit paper · h-index 5

Impact in

Papers in

Joanna Van

6 papers receiving 920 citations

Hit Papers

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial 2018 · 610 citations
6102018202620202023200400600

Peers

Joanna Van
Comparison fields: 5 of 75
  • Endocrinology, Diabetes and Metabolism 698
  • Pharmacology 275
  • Endocrine and Autonomic Systems 87
  • Physiology 267
  • Surgery 273
Replace Daniel A. Briere with:
Daniel A. Briere United States
Lina M. Lauffer Germany
Inmaculada Ruz‐Maldonado United Kingdom
Shridhar N. Iyer United States
Antonio L. Cuesta‐Muñoz Spain
M. Toft-Nielsen Denmark
Sarah Farr Canada
Todd M. Suter United States
Stephan Sachs Germany
Sarah Will United States
Joanna Van relative to Daniel A. Briere United States Daniel A. Briere's profile →
Citations per field
00.5×1.6×
Daniel A. Briere · 1×
Citations per year

Countries citing papers authored by Joanna Van

Since Specialization
Citations

This map shows the geographic impact of Joanna Van's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Van with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Van more than expected).

Fields of papers citing papers by Joanna Van

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Van. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Van. The network helps show where Joanna Van may publish in the future.

Co-authors

The 25 scholars most cited alongside Joanna Van, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joanna Van Line = papers co-authored together Joanna Van links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
Hit paper breakdown →
2018610
2 2020171
3 2016103
4 202141
5 202111
6 20192

About Joanna Van

Joanna Van is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Oncology, Neurology and Molecular Biology, having authored 6 papers that have together received 938 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Metabolism, Diabetes, and Cancer (3 papers), Pharmacology and Obesity Treatment (2 papers), Pancreatic function and diabetes (1 paper), Cancer Treatment and Pharmacology (1 paper), Diabetes Management and Research (1 paper), Pain Mechanisms and Treatments (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (698 citations), Pharmacology (275 citations), Endocrine and Autonomic Systems (87 citations), Physiology (267 citations) and Surgery (273 citations). Joanna Van has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Juan P. Frías, Xuewei Cui, Michael A. Nauck, Axel Haupt, Shweta Urva, Charles Benson, Zvonko Miličević, Deborah A. Robins, Ruth E. Gimeno and Ross Bray. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes Therapy, Journal of Pain, Diabetes and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026